Status:
COMPLETED
Hybrid Method Between Low-ratio Premixed Insulin and Short Acting Insulin in Fasting Type 2 Diabetic Patients in Ramadan
Lead Sponsor:
Sohag University
Conditions:
Continous Blood Glucose Monitoring
Calculation of Body Mass Index
Eligibility:
All Genders
18+ years
Brief Summary
All healthy Muslim adults are required to observe the Ramadan fast, which is one of Islam's five pillars. People with Type 2 Diabetes Mellitus(T2DM). frequently fast throughout Ramadan. However, many ...
Detailed Description
All healthy Muslim adults are required to observe the Ramadan fast, which is one of Islam's five pillars. People with Type 2 Diabetes Mellitus(T2DM). frequently fast throughout Ramadan. Although fast...
Eligibility Criteria
Inclusion
- Egyptian male and female Muslim patients,With T2DM, willing to fast Ramadan
- . age ≥ 18 years old.
- . type 2 diabetic patients treated with premixed insulin alone or combined with oral antidiabetic drugs (metformin, sulfonylurea: gliclazide, dipeptidyl peptidase 4 Inhibitor: sitagliptin or vildagliptin or thiazolidinediones/glitazones).
Exclusion
- type 1 diabetic patients
- uncontrolled type 2 diabetics (HbA1c \> 9; but they were included if insisting on fasting despite the detailed medical advice very high-risk diabetics (according to IDF 2021 classification)9
- newly diagnosed as diabetics (\< 3 months)
- patients with previous ketoacidosis or hyperosmolar hyperglycemic states, recurrent or severe hypoglycemia within the past 2 months
- type 2 diabetic patients with hypoglycemic unawareness.
- Hospitalized patients, besides pregnant and lactating females
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06528002
Start Date
March 1 2024
End Date
June 15 2024
Last Update
January 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag Faculty of Medicine
Sohag, Egypt